Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-28

Clinical Trial Update: Ritanserin in Treatment of Cocaine Dependence - 1 [Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 2 trial evaluating ritanserin for cocaine use disorder, sponsored by the University of Pennsylvania.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ritanserin (ritanserin)

Snippet

Sponsor: University of Pennsylvania | Conditions: Cocaine-Related Disorders | Phase 2 | Status: COMPLETED